Assessment and Treatment of Leg pain Associated with the Spine (ATLAS)

Clinical course, characteristics and prognostic indicators in patients presenting with back and leg pain in primary care

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

ISRCTN

Registry ID

ISRCTN62880786

Enrollment

500

Registered

2011-09-13

Start date

2011-01-01

Completion date

Unknown

Last updated

2019-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Musculoskeletal diseases Musculoskeletal Diseases Musculoskeletal disease

Interventions

1. Patients receive a standardised physiotherapy assessment for back and leg pain and are treated by a study physiotherapist according to need 2. Clinical management will follow agreed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Adults aged 18 years and over consulting their GP with LBP and radiating leg pain of any duration 2. Male or female 3. Lower Age Limit 18, no upper age limit

Exclusion criteria

Exclusion criteria: 1. Persons with ?red flags? indicative of possible serious spinal pathology 2. Serious co-morbidity which stop patients from being able to undergo the assessment 3. Patients with serious mental health problems who are vulnerable and for whom participation in the study would be detrimental (at the GP?s discretion) 4. Previous spinal surgery 5. Pregnancy 6. Currently receiving physiotherapy (or osteopathy, chiropractic) or under a secondary care consultant for the same problem 7. Not able to read and speak English

Design outcomes

Primary

Measure	Time frame
Disability - Roland and Morris Disability Questionnaire (RMDQ, leg pain version) measured at baseline, 4 month and 12 months	—

Secondary

Measure	Time frame
1. Co-morbidity measured at baseline 2. Employment status, work absence, sick certification and difficulties at work measured at baseline, 4 months and 12 months 3. Episode Duration - current episode for each back and leg pain, plus time since ?pain free month? measured at baseline and 12 months 4. General Health (SF1 and EQ5D) measured at baseline, 4 month and 12 month 5. Global assessment of change 0-10 numerical rating scale measured at 4 months and 12 months 6. Health care utilisation measured at 4 months and 12 months 7. Height and Weight measured at baseline 8. Hospital Anxiety and Depression Scale (HADS) measured at baseline and 12 months 9. Illness Perceptions (Musculoskeletal IPQ-R Short Form) measured at baseline, 4 months and 12 months 10. Neuropathic pain (S-LANSS) measured at baseline, 4 month and 12 months 11. Pain intensity (current, average and 'least' pain in the last 2 weeks for both back and leg pain measured at baseline, 4 months and 12 months 12. Pain Location measured at baseline and 12 months 13. Pain Self Efficacy Questionnaire (PSEQ) measured at baseline, 4 months and 12 months 14. Pain trajectory measured at baseline and 12 months 15. Productivity - Performance at work ? single numerical rating scale measured at baseline, 4 months and 12 months 16. Risk of poor outcome (STarT Back tool) measured at baseline, 4 months and 12 months 17. Satisfaction with care measured at 4 months 18. Sciatica Bothersomeness Index (SBI) measured at baseline, 4 months and 12 months 19. Smoking measured at baseline 20. Work Load measured at baseline	—

Measure

Time frame

1. Co-morbidity measured at baseline 2. Employment status, work absence, sick certification and difficulties at work measured at baseline, 4 months and 12 months 3. Episode Duration - current episode for each back and leg pain, plus time since ?pain free month? measured at baseline and 12 months 4. General Health (SF1 and EQ5D) measured at baseline, 4 month and 12 month 5. Global assessment of change 0-10 numerical rating scale measured at 4 months and 12 months 6. Health care utilisation measured at 4 months and 12 months 7. Height and Weight measured at baseline 8. Hospital Anxiety and Depression Scale (HADS) measured at baseline and 12 months 9. Illness Perceptions (Musculoskeletal IPQ-R Short Form) measured at baseline, 4 months and 12 months 10. Neuropathic pain (S-LANSS) measured at baseline, 4 month and 12 months 11. Pain intensity (current, average and 'least' pain in the last 2 weeks for both back and leg pain measured at baseline, 4 months and 12 months 12. Pain Location measured at baseline and 12 months 13. Pain Self Efficacy Questionnaire (PSEQ) measured at baseline, 4 months and 12 months 14. Pain trajectory measured at baseline and 12 months 15. Productivity - Performance at work ? single numerical rating scale measured at baseline, 4 months and 12 months 16. Risk of poor outcome (STarT Back tool) measured at baseline, 4 months and 12 months 17. Satisfaction with care measured at 4 months 18. Sciatica Bothersomeness Index (SBI) measured at baseline, 4 months and 12 months 19. Smoking measured at baseline 20. Work Load measured at baseline

—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 2, 2026